MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'compounding pharmacies'. Sat, 03 Sep 2011 02:59:49 +0100 http://www.medworm.com/index.php?rid=4670336&cid=t_154208_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FCtZxAGEWEqs%2F You read it here first. Despite the decision today by KV Pharma to lower the price of its Makena drug for premature births by 55 percent - to $690 (see this), the March of Dimes has ended a decade-long corporate relationship in which the drugmaker contributed some $1 million to help support various activities, such as a neo-natal family intensive care program. The move comes after the organization met earlier this week with the embattled drugmaker, which has faced a storm of protest after initially charging $1,500 for Makena, a form of progesterone that, for many years, was offered by compounding pharmacies. KV was granted marketing exclusivity because approval was made under the Orphan Drug Act and the drugmaker threatened to take compounding pharmacies to court. To mollify critics, KV su... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4670336 Fri, 01 Apr 2011 21:10:12 +0100 4670336 http://www.medworm.com/index.php?rid=4664479&cid=t_154208_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FgXjtOBKbmts%2F Yesterday, the FDA took the unusual step of inserting itself into the controversy over the KV Pharmaceutical drug known as Makena, which the agency approved last month for premature births under the Orphan Drug Act. After KV disclosed plans to charge $1,500, compared with $10 to $20 a week for compunded versions of a med that has been used for decades, the drugmaker and the FDA came under fire by politicians, patient groups and some doctors (see this and this). In response, the FDA says it will not prevent compounders from compounding (see this), adding unexpected to competition to KV, which has a 7-year exclusivity period. We spoke with Cole Werble (pictured left) and Ramsey Baghdadi who track pharma for Prevision Policy, a healthcare analysis firm, and who are also editors at The RPM Rep... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4664479 Thu, 31 Mar 2011 13:15:26 +0100 4664479 http://www.medworm.com/index.php?rid=4658621&cid=t_154208_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F_coAu5MMn48%2F In response to threats KV Pharmaceuticals has made to compounding pharmacies that want to continue making low-cost versions of its high-priced Makena preemie drug, the FDA has just issued a statement saying the agency will not take any “enforcement actions” against compounders. The “FDA understands that the manufacturer of Makena, KV Pharmaceuticals, has sent letters to pharmacists indicating that FDA will no longer exercise enforcement discretion with regard to compounded versions of Makena. This is not correct,” the FDA statement says. “In order to support access to this important drug, at this time and under this unique situation, FDA does not intend to take enforcement action against pharmacies that compound hydroxyprogesterone caproate based on a valid pr... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4658621 Wed, 30 Mar 2011 14:43:43 +0100 4658621 http://www.medworm.com/index.php?rid=4610997&cid=t_154208_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fp-iLT_qgFpc%2F Two senators want the US Federal Trade Commission to investigate the price that KV Pharmaceuticals is charging for its brand new Makena med for high-risk pregnancies, given that versions of the same drug have been available from compounding pharmacies for many years at a fraction of the cost. The drugmaker, they charge, is price gouging. The cost of the treatment went from roughly $10 to $20 to $1,500 after KV received FDA approval earlier this year. And KV has also sent letters to compounding pharmacies warning them about continuing to make the treatment or face possible legal action. A trade group representing compounders pooh-poohed the threat, but patients, doctors and insurers are outraged at the price tag (back story). Investors, however, believe Makena represents a remarkable turnar... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4610997 Fri, 18 Mar 2011 19:39:45 +0100 4610997 http://www.medworm.com/index.php?rid=4570759&cid=t_154208_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FWSS2nrAw5gE%2F This week, the cost of an injection to prevent a premature birth is roughly $10 to $20. Next week, it will cost $1,500. Why? That is when KV Pharmaceutical starts marketing its newly approved Makena, a form of progesterone that, for many years, was offered by compounding pharmacies. Now, though, KV has an exclusive lock on the market and is threatening compounders who dare to encroach. “I’ve never seen anything as outrageous as this,” Arnold Cohen, an obstetrician at Albert Einstein Medical Center, tells the Associated Press. “That’s a huge increase for something that can’t be costing them that much to make,” says Roger Snow, deputy medical director for Massachusetts Medicaid. And Joanne Armstrong, who heads women’s health at Aetna, says: &#8... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4570759 Thu, 10 Mar 2011 14:52:04 +0100 4570759 http://www.medworm.com/index.php?rid=3607757&cid=t_154208_135_f&fid=35262&url=http%3A%2F%2Fsurvivinghiv.blogspot.com%2F2010%2F05%2Fnew-book-testosterone-mans-guide-by.html (Source: Nelson Vergel's HIV Blog) Nelson Vergel's HIV Blog blogs http://www.medworm.com/rss/comments.php?id=3607757 Thu, 27 May 2010 16:46:00 +0100 3607757 http://www.medworm.com/index.php?rid=1309054&cid=t_154208_135_f&fid=35262&url=http%3A%2F%2Fsurvivinghiv.blogspot.com%2F2008%2F03%2Fimportant-information-about-nandrolone.html QUESTION FROM SOMEONE IN MY POZHEALTH AT YAHOOGROUPS.COM LIST:"I interpret this that once the current supply of the components tomake nandrolone are depleted, there will be no more access tonandrolone here in the US. Am I right or just the number ofcompounding pharmacies may continue to dwindle due to DEA pressures?Thanks everyone,Tom A"MY ANSWER:Dear TomThe ingredients to make nandrolone are not depleted. The decision from the manufacturer (Watson) to stop making nandrolone decanoate (an effective injectable medicine to treat unintentional weight loss and to increase muscle mass) was based on economics and political pressure.Watson stopped making it because:1- It is a generic CHEAP drug2- They can sell expensive Oxandrin instead. Oxandrin is approved for unintentional weight loss but cost... Nelson Vergel's HIV Blog blogs http://www.medworm.com/rss/comments.php?id=1309054 Mon, 17 Mar 2008 21:52:00 +0100 1309054 http://www.medworm.com/index.php?rid=1232034&cid=t_154208_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F235168667%2F In October 2005, Wyeth filed a citizen’s petition with the FDA in an effort to stop compounding pharmacies from making bioidentical versions of Prempro, its controversial hormone replacement therapy, which some women claim in lawsuits has caused them to develop breast cancer. Last month, the FDA responded by sending warning letters to seven compounders that their claims about the safety and effectiveness of their BHRT products are unsupported by medical evidence, and are considered false and misleading. The FDA explained that the drugs made by the compounding pharmacies contain hormones such as estrogen, progesterone and estriol, which the agency made a point of noting isn’t a component of any approved drug and hasn’t been proven safe and effective for any use. And this m... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1232034 Thu, 14 Feb 2008 21:03:34 +0100 1232034 http://www.medworm.com/index.php?rid=1225635&cid=t_154208_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F233717678%2F Stung by a crackdown on unproven claims about the safety and effectiveness of medications made by compounding pharmacies to treat menopause, supporters of the drugs have launched a lobbying campaign aimed at the FDA, The Washington Post writes. Last week, the HOME (Hands Off My Estrogens!) Coalition, a group based in Edinburg, Va., placed a full-page ad in five newspapers, including USA Today and the Wall Street Journal, accusing the agency of being hostile to “natural” hormonal medicines made according to a doctor’s prescription by a compounding pharmacy. The ads urge women and their physicians to e-mail the White House and members of Congress asking them to protect patient access to meds they claim are “bio-identical” to those found in the body, the Post r... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1225635 Tue, 12 Feb 2008 12:06:28 +0100 1225635 http://www.medworm.com/index.php?rid=1148197&cid=t_154208_87_f&fid=35052&url=http%3A%2F%2Fwomensbioethics.blogspot.com%2F2008%2F01%2Fdrama-surrounding-juice-of-youth-fda.html (Source: Women's Bioethics Blog) Women's Bioethics Blog blogs http://www.medworm.com/rss/comments.php?id=1148197 Mon, 14 Jan 2008 02:07:00 +0100 1148197 http://www.medworm.com/index.php?rid=1140029&cid=t_154208_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F213970192%2F The agency sent warning letters to seven compounding pharmacies operations that their claims about the safety and effectiveness of their allegedly bio-identical hormone replacement therapy, or BHRT products, are unsupported by medical evidence, and are considered false and misleading. The move comes, partly, in response to a citizen’s petition filed by Wyeth, which wants to stop compounding pharmacies from making bioidentical versions of Prempro. In doing so, however, Wyeth caused a bit of a ruckus among women who oppose the use of the synthetic med, which has been the subject of lawsuits over ties to breast cancer. However, the FDA says these seven pharmacy operations improperly claim their drugs, which contain hormones such as estrogen, progesterone, and estriol (which is not a com... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1140029 Wed, 09 Jan 2008 19:51:12 +0100 1140029 http://www.medworm.com/index.php?rid=987252&cid=t_154208_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F176618124%2F Welcome to the working week. We hope you enjoyed your weekend and feel refreshed. Now, the time has come to return your thoughts to those project and meetings. Here are a few items to help you with the transition… Novartis Plans $700M Biotech Plant In Singapore (Bloomberg News) Bayer’s Betaferon MS Drug Fails In Higher Doses (Yahoo/Reuters) FDA Tells Takeda To Halt Some Studies Of Its Experimental Cholesterol Drug (Bloomberg News) Sepracor Fights Compounding Pharmacies (Worcester Business Journal) Hepatitis C Victims Kept In The Dark (Daily Yomuiri Online) Share / E-mail (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=987252 Mon, 29 Oct 2007 11:06:57 +0100 987252